GT Biopharma Provides Enrollment Update on GTB-3650 Phase 1 Trial in Patients with Relapsed or Refractory (r/r) CD33 Expressing Hematologic Malignancies
The formal safety review of Cohort 3 (5ug/kg/day) has been successfully completed…
CGTN: The Stilwell Road at 80: Honoring China-U.S. Cooperation and Friendship
BEIJING, Sept. 8, 2025 /PRNewswire/ -- In 2023, President Xi Jinping wrote back…
Casio to Deliver Metaverse-Based Experiences in Collaboration Between G-SHOCK and The Sandbox
Offering Limited-Edition NFTs and Game Content Expressing the Brand's Worldview TOKYO, Aug.…